Thanks, Don. As Don highlighted during his comments our financial performance during the first quarter was solid and keeps us on track to deliver 2016 results in line with our guidance. Total revenue grew 40% versus the first quarter of 2015 and contributed to strong growth in gross profit, adjusted EBITDA and earnings per share. This performance was driven by an increasingly diverse base of demand, volume growth supported by our third production line and improvements in manufacturing productivity. I’d like to start by running through our reported financial results for the first quarter at a summary level. First quarter total revenue grew 40% year-over-year to $32.8 million. First quarter gross profit grew 45% year-over-year to $6.5 million. First quarter GAAP net loss was $1.8 million or $0.08 per share versus a net loss of $2.8 million or $0.12 per share in the first quarter last year. And adjusted EBITDA for the quarter nearly tripled the $2 million this year versus $734,000 a year ago. We defined adjusted EBITDA has net income or loss before interest, taxes, depreciation, amortization, stock-based compensation expense and other items that we do not believe are indicative of our core operating performance. I will now provide additional detail on the components of our results. First, I will discuss revenue. First quarter total revenue is comprised of product revenue of $32.3 million and research services revenue of $535,000. During the quarter, product revenue increased 39% versus last year. This growth was due to strong demand in the petrochemical market in Asia, a significant subsea project and resurgent demand in the building materials market in Europe. We also substantially completed deliveries on our first large scale LNG project during the period. During the first quarter, we shipped 11.8 square feet of aerogel blankets, which represented growth of 35% versus the first quarter of 2015 and was supported by output from our third production line. And our first quarter average selling price increased 3% versus the first quarter of 2015 to $2.73 per square foot and reflected the impact of price increases over the past year offset in part by a shift in mix the lower priced products. I will now turn to research services revenue. Our research services revenue was related to contract research performed principally for government agencies. Research revenue increased 85% during the first quarter to $535,000 due to the relative value and timing of contracts versus the first quarter of 2015. For the full year, we expect research services revenue to be approximately $2 million, essentially flat with 2015 revenue levels. This expectation is included in our 2016 financial guidance. Next I'll discuss gross profit. Our gross profit grew 45% to $6.5 million during the first quarter, and our gross margin of 20% represented an increase of one percentage point from the first quarter of 2015. The increase in gross profit was driven by strong volume growth, supported by the third production line and improvements in manufacturing productivity. By 2016 increase also contributed to the gross profit increase. Next I’ll discuss operating expenses. First quarter operating expenses grew $1 million or 14%, $8.3 million. The increase in operating expense included $700,000 for increased investment in sales, personnel, and marketing programs. $200,000 in patent enforcement related legal costs, and $100,000 in non-cash stock compensation expense. Our patent enforcement actions may require significant legal expenditures over the next few years. The amount and timing of these legal costs will be difficult to predict. We will report actual costs of the enforcement actions incurred on a quarterly basis. Again, our patent enforcement legal costs for $200,000 during the first quarter of 2016. And next I'll discuss our balance sheet and cash flow. In spite generating $2 million in EBITDA, we used $200,000 of cash to fund operating activities due to a temporary increase in working capital. Capital expenditures of $3.1 million during the quarter, included engineering design and other pre-construction costs for our plant Statesboro, Georgia plant, and betterment and additions within our East Providence Rhode Island facility We ended the first quarter with $29.4 million of cash and minimal debt, net current assets of $42.5 million, shareholders' equity of $122 million. In addition, our $20 million revolving credit facility remains untapped. We're updating our financial outlook for 2016. Total revenue is expected to range between $117 million and $125 million, up slightly from prior guidance of $117 million to $122 million. GAAP EPS is expected to range between a loss of $0.09 and a loss of $0.016 per share, down slightly from prior guidance of a loss of $0.06 to a loss of $0.15 per share. This GAAP EPS guidance assumes weighted average shares outstanding of 23.2 million shares for the year. Adjusted EBITDA is expected to range between $11.5 million and $13 million, unchanged from prior guidance. This 2016 outlook assumes depreciation and amortization of between $9.6 million and $9.8 million, stock-based compensation expense of between $5.2 million and $5.4 million, and interest expense of $200,000. This 2016 outlook specifically excludes the cost of patent enforcement actions incurred in the first quarter expect to incur during the remainder of 2016. The amount and timing of these litigation costs are difficult to predict. We will continue to report actual costs in enforcement actions incurred on a quarterly basis. While we don't plan to provide specific quarterly guidance, we think it's important to provide our investors with a general view to our expectations during the year. We are reaffirming the following guidance we provided in our fourth quarter conference call. We expect revenue in the range of $60 million to $65 million in the first half of 2016 in the range of %55 million to $60 million during the second half of the year. Due to anticipated changes in the mix of products sold, we expect gross margin to be in the low-20%s during the first half of 2016 with an increase to the mid-20%s during the second half of 2016. We also expect operating expense levels to be slightly higher in the first half than in the second half of the year excluding the impact of patent enforcement costs. In line with this anticipated product mix and timing of operating expenses, we expected adjusted EBITDA to be lower in the first half of the year and to trend higher during the second half of the year. And as always, project work and product mix can create quarterly variability. In addition the cost of the patent enforcement actions may be material and they’re excluded from our present guidance. I now turn the call back to Erin for any Q&A.